During the past decade, Hospital Universitario de Guadalajara conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 18 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 12 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario de Guadalajara" #1 sponsor was "PETHEMA Foundation" with 8 trials, followed by "Spanish Breast Cancer Research Group" with 7 trials sponsored, "Centro Nacional de Investigaciones Oncologicas CARLOS III" with 4 trials sponsored, "Grupo Español de Rehabilitación Multimodal" with 4 trials sponsored and "Fundacion SEIMC-GESIDA" with 4 trials sponsored. Other sponsors include 49 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario de Guadalajara" #1 collaborator was "Apices Soluciones S.L." with 5 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator, "Hoffmann-La Roche" with 3 trials as a collaborator, "Roche Farma, S.A" with 3 trials as a collaborator and "AstraZeneca" with 2 trials as a collaborator. Other collaborators include 56 different institutions and companies that were collaborators in the rest 57 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario de Guadalajara" are "Breast Cancer" (8 trials), "Advanced Prostate Cancer" (4 trials), "Multiple Myeloma" (4 trials), "COVID-19 Infection" (3 trials) and "Fibromyalgia" (3 trials). Many other conditions were trialed in "Hospital Universitario de Guadalajara" in a lesser frequency.

Most popular intervention types in "Hospital Universitario de Guadalajara" are "Drug" (47 trials), "Other" (7 trials), "Procedure" (4 trials), "Device" (2 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Cyclophosphamide" (4 trials), "Dexamethasone" (3 trials), "placebo" (3 trials) and "Capecitabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario de Guadalajara" are 56 trials for "All" genders, 16 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitario de Guadalajara". 1 are not yet recruiting, 4 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 53 completed trials in Hospital Universitario de Guadalajara, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario de Guadalajara, 3 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 4 trials that are defined as “Not Applicable".

Hospital Universitario de Guadalajara has several departments that took part in Clinical trials: "Hospital General Universitario de Guadalajara; Servicio de Oncologia" - 3 trials, "Hospital General Universitario de Guadalajara; Servicio de Dermatologia" - 2 trials, "Hospital General Universitario de Guadalajara; Servicio de Reumatologia" - 2 trials